This activity is designed to change: Competence, Performance, Patient Outcome. 4hr(s)
After completing this activity participants will be able to:
- Describe the biological pathways and hormones involved in regulating appetite and weight and how they are modified in chronic obesity
- Recommend and prescribe weight-loss medications to patients, when appropriate, as an adjunct to routine weight management.
- Refer patients for bariatric surgery when appropriate and provide care for patients who have had the surgery
- Select weight-neutral or weight-negative medications that could replace patients’ current weight-gaining medications.
Modules in this Training Activity
Training Activity References
AUDIENCE AND ACCREDITATION
Audience:Healthcare providers in a medical setting
|AMA PRA Category 1 Credit(s)™||4hr(s)||4/1/18||3/31/21|
Accreditation Statement: Clinical Tools, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DCBN Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 hour(s) of DCBN credit. Clinical Tools, Inc. is an approved provider by the District of Columbia Board of Nursing and is registered with CE Broker, Provider #50-1942.
NBCC Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 clock hour(s) of NBCC credit. Clinical Tools, Inc. has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6161. Activities that do not qualify for NBCC credit are clearly identified. Clinical Tools is solely responsible for all aspects of the activity.
AMA Credit Designation Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A letter of completion for up to 4 hour(s) is available for non-physicians.
A score of 70% on the post-test is required to complete the activity.
Initial development of this activity was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (#2R44DK091144-01A1).